The autocrine action of salidroside on osteoclast during osteoclastogenesis via hypoxia-inducible factor-1 α pathway
Human & Experimental Toxicology · 2024
DOI: 10.1177/09603271241269028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human & Experimental Toxicology, 2024. Verfasst von Yutong Jin und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Hauptthemen laut MEDLINE: Glucosides, Phenols, Hypoxia-Inducible Factor 1, alpha Subunit, Osteoclasts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Great Program of the Science Foundation of Tianjin, Heilongjiang Province Fund.
Abstract (Originalsprache)
Background and objective The objective of this study was to investigate the potential of salidroside (SAL) (a major active compound in Rhodiola rosea L.) in regulating osteoclast differentiation and function by modulating the HIF-1 α pathway and its downstream target genes.
Methods
The expression of HIF-1 α and its downstream target genes was examined at both mRNA and protein levels in osteoclasts treated with SAL. Immunofluorescence analysis was performed to assess the nuclear translocation and transcriptional activity of HIF-1 α in response to SAL. MTT, flow cytometry, qPCR, TRAP staining and bone resorption assays were used to evaluate the potential effect of salidroside on osteoclasts.
Results
SAL enhanced the expression of HIF-1 α and its downstream target genes in osteoclasts. Immunofluorescence analysis confirmed the facilitation of HIF-1 α nuclear translocation and transcriptional activity by SAL. In addition, SAL enhanced osteoclast viability, differentiation and bone resorption activity in an autocrine manner through HIF-1 α/VEGF, IL-6 and ANGPTL4 pathways.
Conclusion
SAL promotes osteoclast proliferation, differentiation and bone resorption through HIF-1 α/VEGF, IL-6 and ANGPTL4 pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Department of Orthodontic, Tianjin Stomatological Hospital, Tianjin, China.
- Department of Pharmacy, Characteristic Medical Center of Chinese People's Armed Police Force, Tianjin, China.
- Department of Orthopaedics, Tianjin First Central Hoapital, Tianjin, China.
ORCID-Profile: Yue Wang
Förderung
- National Natural Science Foundation of China
- Great Program of the Science Foundation of Tianjin
- Heilongjiang Province Fund
- Ministry of Education “Chunhui plan” cooperative scientific research project
- Tianjin University of Traditional Chinese Medicine Talented Youth Program
Zitieren
APA
Jin, Y., Li, Z., Qi, L., Zhang, L., Gao, D., Liu, H., Cao, Q., Tian, C., Xia, Q., & Wang, Y. (2024). The autocrine action of salidroside on osteoclast during osteoclastogenesis via hypoxia-inducible factor-1 α pathway. Human & Experimental Toxicology. https://doi.org/10.1177/09603271241269028
Vancouver
Jin Y, Li Z, Qi L, Zhang L, Gao D, Liu H, et al. The autocrine action of salidroside on osteoclast during osteoclastogenesis via hypoxia-inducible factor-1 α pathway. Human & Experimental Toxicology. 2024. doi:10.1177/09603271241269028
BibTeX
@article{Jin2024,
author = {Jin, Yutong and Li, Zhengyang and Qi, Lin and Zhang, Lingling and Gao, Dandan and Liu, Haizhao and Cao, Qingwen and Tian, Chenchen and Xia, Qun and Wang, Yue},
title = {The autocrine action of salidroside on osteoclast during osteoclastogenesis via hypoxia-inducible factor-1 α pathway},
journal = {Human & Experimental Toxicology},
year = {2024},
doi = {10.1177/09603271241269028}
}
EUVIMED